Research & Development

A Long-Term Commitment to Health Innovation

At Hovid, we understand that the battle against diseases is an ongoing challenge. We believe that passion drives every breakthrough, empowering us to push the boundaries of healthcare services. Innovation is at the heart of our mission to develop new, patented formulations that contribute to the prevention and treatment of diseases.

Fighting to Improve People’s Health

Professional Scientists & Laboratory Executives

Bioequivalence (BE) Studies completed

Products in the R&D Pipeline

Clinical Trials

Our Qualified Facilities

Tailored to Meet Customer Needs

Hovid’s R&D division, known as Attest Research Sdn Bhd, is based at our Chemor manufacturing plant, where a dedicated team drives pharmaceutical product development and innovation. This centralized hub is equipped with advanced technologies to support research, testing, and continuous improvement, ensuring that every Hovid product meets the highest standards of quality, efficacy, and safety.

At Attest, our focus goes beyond developing traditional medicines. We develop a wide range of pharmaceutical formulations, including oral, topical, and soft gelatin preparations, designed to meet different therapeutic needs. At the same time, our team continues to explore new and improved drug delivery systems, such as controlled-release and enhanced bioavailability formulations, with the aim of making treatments more effective and accessible for patients everywhere. 

What we do

Product Development

Product Development

  • Solid, semi-solid and liquid oral dosage forms
  • Topical preparations, including emulsions, suspensions, creams and ointments
  • Soft gelatin preparations

Drug Delivery System Innovation

Drug Delivery System Innovation

  • Controlled-release formulations
  • Enhanced oral bioavailability formulations

Stability Studies & Testing

Stability Studies & Testing

  • 25°C ± 2°C / 60% ± 5% RH
  • 30°C ± 2°C / 75% ± 5% RH
  • 40°C ± 2°C / 75% ± 5% RH

Clinical & Analytical Support

Clinical & Analytical Support

  • Critical studies
  • Testing & documentation
  • Quality & regulatory compliance

First “6” Achievements in Malaysia

First to develop a commercial process for extracting Palm Tocotrienols

First to develop a self-emulsifying SupraBioTM system

First to have a soft gelatin encapsulation plant

First to produce film-coated analgesics, softgel capsules & effervescent tablets

First to produce antibiotics in dispersible tablet form

First to develop patented technologies in drug delivery systems

Search
×